Insider Transactions Reported by 14 Insiders of Regulus Therapeutics Inc.

Location
San Diego, CA

Insiders trading volume in the past year

Regulus Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Preston Klassen President & Head of R & D, Director $383,848 +$95,852 +33% 25 Jun 2025
Denis Drygin Chief Scientific Officer $119,060 01 Mar 2022
Pascale Witz Director $0 25 Jun 2025
WILLIAM H. RASTETTER Director $0 25 Jun 2025
DAVID BALTIMORE Director $0 +$20,787 25 Jun 2025
CRISPINA CALSADA Chief Financial Officer $0 25 Jun 2025
Christopher Aker Sr. VP & General Counsel $0 25 Jun 2025
STELIOS PAPADOPOULOS Director $0 25 Jun 2025
Jason Raleigh Nunn Director $0 25 Jun 2025
Kathryn J. Collier Director $0 25 Jun 2025
Hugh Rosen Director $0 25 Jun 2025
Alice Shih-hou Huang Director $0 25 Jun 2025
Joseph P. Hagan Chief Executive Officer, Director $0 +$54,260 25 Jun 2025
Simos Simeonidis Director 09 Jun 2022

Recent Insider Transactions by Companies or Individuals for Regulus Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.